Glucose, insulin, and potassium for metabolic support in acute myocardial infarction: Is the jury still out?

Reviews in Cardiovascular Medicine

Volumn 7, Issue SUPPL. 2, 2006, Pages

  Broder, Howard J ^a   Nesto, Richard W ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Acute myocardial infarction; Free fatty acids; Glucose, insulin, potassium

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; FATTY ACID; GLUCOSE; GLUCOSE PLUS INSULIN PLUS POTASSIUM; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; LACTIC ACID; NITRATE; POTASSIUM CHLORIDE; PROTON; STREPTOKINASE; UNCLASSIFIED DRUG; UROKINASE;

ACUTE HEART INFARCTION; ARTICLE; CARDIOMYOPATHY; CELL SURVIVAL; CLINICAL TRIAL; DIABETES MELLITUS; DIASTOLE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; LOW DRUG DOSE; META ANALYSIS; MULTIPLE DRUG DOSE; PROTEIN TRANSPORT; REPERFUSION INJURY; SARCOLEMMA; ST SEGMENT ELEVATION; SYSTEMATIC REVIEW;

CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HUMANS; HYPERGLYCEMIA; INFUSIONS, PARENTERAL; INSULIN; MYOCARDIAL INFARCTION; MYOCARDIUM; PATIENT SELECTION; POTASSIUM; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33846427360     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sodi-Pallares D, Testelli MR, Fischleder BL. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol. 1962;9:166-181.
2. Mittra B. Potassium, glucose, and insulin in treatment of myocardial infarction. Lancet. 1965;2:607-609.
3. Lee L, Jorowitz J, Frenneaux M. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur Heart J. 2004;25: 634-641.
4. Stanley WC, Lopaschuk GD, Hall JL, et al. Regulation of myocardial carbohydrate metabolism under normal and ischemic conditions. Potential for pharmacological interventions. Cardiovasc Res. 1997;33:243-257.
5. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis. 1981;23:321-336.
6. Opie LH. The glucose hypothesis: relation to acute myocardial ischemia. J Mol Cell Cardiol. 1970;1:107-114.
7. De Leiris J, Opie LH, Lubbe WF. Effects of free fatty acid and glucose on enzyme release in experimental myocardial infarction. Nature. 1975;253:746-747.
8. Gmeiner R, Apstein CS, Brachfeld N. Effect of palmitate on hypoxic cardiac performance. J Mol Cell Cardiol. 1975;7:227-235.
9. Apstein CS, Opie LH. A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J. 2005;26:956-959.
10. Zarich SW. The role of intensive glycemic control in the management of patients who have acute myocardial infarction. Cardiol Clin. 2005;23:109-117.
11. Young LH, Renfu Y, Russell R, et al. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 1997;95:415-422.
12. Sun D, Nguyen N, DeGrado TR, et al. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation. 1994;89: 793-798.
13. Russell RR III, Yin R, Caplan MJ, et al. Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo. Circulation. 1998;98:2180-2186.
14. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest. 2004;114:1187-1195.
15. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
16. Van den Berghe G, Wouters P, Weekers F, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359-366.
17. Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006;27:1289-1297.
18. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152-1156.
19. Rogers WJ, Stanley AW, Breinig JB, et al. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J. 1976;92:441-454.
20. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
21. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
22. Van der Horst IC, Zijlstra F, van't Hof AWJ, et al. Glucose-insulin-potassium Study: a randomized trial. J Am Coll Cardiol. 2003;42:784-791.
23. Apstein CS. The benefits of glucose-insulin-potassium for acute myocardial infarction (and some concerns). J Am Coll Cardiol. 2003;42:792-795.
24. Van der Horst IC, Timmer JR, Ottervanger JP, et al. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS2). Am Heart J. 2005; 149:585-591.
25. Timmer JR, Svilaas T, Ottervanger JP, et al. Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the glucose-insulin-potassium study (GIPS)-II. J Am Coll Cardiol. 2006;47:1730-1731.
26. Diaz R, Paolasso EA, Piegas LS, et al. ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Metabolic modulation of acute myocardial infarction. Circulation. 1998;98:2227-2234.
27. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437-446.
28. OASIS-6 - Glucose-Insulin-Potassium. Presented by R. Diaz, European Society of Cardiology Scientific Congress, September 2-6, 2000; Barcelona, Spain.
29. IMMEDIATE Trial Web site. Available at: http://www.immediatetrial.com. Accessed October 9, 2006.
30. Wexler L, Ingwall JS. In Memoriam Carl S. Apstein, MD 1941-2005. Circulation. 2006;114:867-868.